Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?

Author： Bedussi Francesca Bottini Alberto Memo Maurizio Fox Stephen B Sigala Sandra Generali Daniele

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.18, Iss.6, 2014-06, pp. : 665-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

By Heinzle Christine Sutterlüüty Hedwig Grusch Michael Grasl-Kraupp Bettina Berger Walter Marian Brigitte

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 829-846

Informa Healthcare

Access to resources Recommend Favorite

Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2881-2898

Bentham Science Publishers

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 687-701

Bentham Science Publishers

Access to resources Recommend Favorite

Sales of human epidermal growth factor receptor 2 (HER2)-targeting breast cancer therapies are set to grow by 3.3% per annum

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer: State of the Art

By Diasio Robert B. Fourie Jeanne

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1441-1463

Adis International

Access to resources Recommend Favorite